Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.2 to v3.6.3, indicating an administrative update to the study record. This reflects an administrative change rather than updates to the study data.
    Difference
    0.1%
    Check dated 2026-07-06T15:49:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study page. There is no change to substantive study information such as eligibility criteria, endpoints, or locations.
    Difference
    0.1%
    Check dated 2026-06-29T08:46:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate enrollment is closed, reflecting a completed study. Additional changes introduce new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revision label update, signaling UI/content organization updates.
    Difference
    0.4%
    Check dated 2026-06-14T20:37:55.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a newer revision label, v3.5.5, replacing the previous v3.5.4. This reflects a maintenance or content-management update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-07T15:51:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a new version of the page content or formatting.
    Difference
    0.1%
    Check dated 2026-05-15T23:16:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page updates outcome reporting by adding concrete follow-up time points for progression-free survival and expanding observation periods for adverse events and post-treatment follow-up, reflecting updated data collection planning.
    Difference
    0.5%
    Check dated 2026-05-08T23:55:11.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.